Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
European Journal of Cancer (Oxford, England : 1990)|March 17, 2009
Estimation of an optimal chemotherapy utilisation rate for head and neck carcinoma: setting an evidence-based benchmark for the best-quality cancer careWeng Ng, Susannah Jacob, Geoff Delaney, et al.
Cancer|December 16, 2004
Estimating the optimal utilization rates of radiotherapy for hematologic malignancies from a review of the evidence: part I-lymphomaCarolyn Featherstone, Geoff Delaney, Susannah Jacob, et al.
Cancer|December 14, 2004
Estimating the optimal utilization rates of radiotherapy for hematologic malignancies from a review of the evidence: part II-leukemia and myelomaCarolyn Featherstone, Geoff Delaney, Susannah Jacob, et al.
The Lancet. Oncology|January 24, 2021
Evidence-based benchmarks for use of cancer surgery in high-income countries: a population-based analysisSathira Kasun Perera, Susannah Jacob, Richard Sullivan, et al.
Gastroenterology Research and Practice|April 18, 2015
Estimation of an optimal chemotherapy utilisation rate for upper gastrointestinal cancers: setting an evidence-based benchmark for the best-quality cancer careWeng Ng, Susannah Jacob, Geoff Delaney, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2009
Estimation of an optimal chemotherapy utilisation rate for breast cancer: setting an evidence-based benchmark for the best-quality cancer careWeng Ng, Geoff P Delaney, Susannah Jacob, et al.
Clinical and Translational Radiation Oncology|March 14, 2022
Optimal and actual rates of Stereotactic Ablative Body Radiotherapy (SABR) utilisation for primary lung cancer in AustraliaWsam Ghandourh, Lois Holloway, Vikneswary Batumalai, et al.
Clinical Colorectal Cancer|August 24, 2011
Chemotherapy in rectal cancer: variation in utilization and development of an evidence-based benchmark rate of optimal chemotherapy utilizationSusannah Jacob, Weng Ng, Ray Asghari, et al.
European Journal of Cancer (Oxford, England : 1990)|June 17, 2009
Estimation of an optimal chemotherapy utilisation rate for colon cancer: an evidence-based benchmark for cancer careSusannah Jacob, Weng Ng, Ray Asghari, et al.
Cancer|November 17, 2006
Estimation of the optimal brachytherapy utilization rate in the treatment of carcinoma of the uterine cervix: review of clinical practice guidelines and primary evidenceStephen Thompson, Geoff Delaney, Gabriel Sam Gabriel, et al.
Pageof 4